17:03 IST
BSE
Other Announcement
Kabra Drugs Other Announcement
Aanjaay Industries Limited has shifted its registered office from Indore, Madhya Pradesh, to Chennai, Tamil Nadu, effective August 28, 2026.
Kabra Drugs Ltd
- Share price
- ₹18.65
- Market cap
- ₹44.22 Cr
- Revenue (annual)
- ₹92.74 Cr
- Net profit (annual)
- ₹4.96 Cr
- P/E (TTM)
- 5.8×Sector 47.4×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Financial Results 4Board Meeting Date 4Annual General Meeting 4Board Meeting Outcome 3Management Change 2Capacity Expansion 2Results Update 1Legal & Regulatory 1Capital Structure Change 1Annual Report 1
Time
5 announcements with these filters
18:27 IST
BSE
Other Announcement
Kabra Drugs Other Announcement
Aanjaay Industries Limited has filed its updated Board and Committee composition list in compliance with SEBI (LODR) regulations.
17:51 IST
BSE
Other Announcement
Kabra Drugs Other Announcement
Kabra Drugs Ltd has filed its quarterly shareholding pattern for the quarter ended June 30, 2026, in compliance with SEBI regulatory requirements.
12:19 IST
BSE
Other Announcement
Kabra Drugs Other Announcement
Kabra Drugs Ltd has changed its name to Aanjaay Industries Limited effective July 6, 2026. The fresh Certificate of Incorporation has been filed with BSE.
16:03 IST
BSE
Other Announcement
Kabra Drugs Other Announcement
Kabra Drugs Limited has submitted its quarterly compliance certificate for the period ended March 31, 2026, as per SEBI regulations. The Registrar and Share Transfer Agent, Skyline Financial Services, confirmed that physical share certificates received for dematerialization were duly verified, mutilated, and cancelled within 15 days.